50 years experience
in small molecule field

Since the early 1970s, Kaneka has been manufacturing numerous specialty pharmaceutical targets using a combination of synthetic and biotechnology, with a specialty in chiral compounds. The 2018 addition of a Kaneka designed continuous flow system for use at commercial scale has expanded our technology offerings to the market, and is an excellent complement to our existing technology platform.

Read more